BioNxt Signs Statement of Work With International Contract Research, Development, And Manufacturing Organization for Cladribine ODF Development

AccesswireJul 17 15:05

BioNxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement

AccesswireJun 20 07:00

BioNxt Solutions Announces ODF Cladribine Update and Financing

AccesswireApr 26 11:50

BioNxt Reports Commercialization of ODF Cladribine Product for MS Next Steps

AccesswireMar 18 15:05

BioNxt Reports Successful Results From ODF Cladribine PK Study

AccesswireMar 13 15:05

BioNxt Reports Completion of ODF Cladribine PK Study

AccesswireMar 2 10:25